Sleep Disorders Differ for Autism, ADHD Versus Typical Development
22 Jan 2024
Clinical Result
MONDAY, Jan. 22, 2024 -- For most types of sleep disorders, there are significant differences for children with autism spectrum disorder (ASD) and those with attention-deficit/hyperactivity disorder (ADHD) compared with typically developing (TD) children, according to a study published online Dec. 29 in Autism Research.
Carmen Berenguer, Ph.D., from the Universitat de València in Spain, and colleagues examined the differences in sleep problems among a group of children with ASD without intellectual disabilities, a group with ADHD, and a TD group (47, 43, and 32 children, respectively; aged 7 to 12 years) matched on age and intelligence. Questionnaires measuring sleep disturbances and communication skills were completed by parents.
The researchers identified significant differences in most types of sleep disorders between the ASD and ADHD groups and the TD group. The group with ADHD showed significantly more sleep breathing disorders and hyperhidrosis compared with the ASD and TD groups, as well as more total sleep problems. Compared with the ASD group, the ADHD group had greater predictive power of sleep problems on communication difficulties. Sleep problems were found to partially mediate the association between symptoms and communication in both groups.
"Understanding the sleep dysfunctions that occur in both conditions and their repercussion in other areas such as communication is crucial for developing tailored interventions that reduce the adverse consequences of sleep disturbances," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.